Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

696 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2.
Jereczek-Fossa BA, Pepa M, Zaffaroni M, Marvaso G, Bruni A, Buglione di Monale E Bastia M, Catalano G, Filippi AR, Franco P, Gambacorta MA, Genovesi D, Iatì G, Magli A, Marafioti L, Meattini I, Merlotti A, Mignogna M, Musio D, Pacelli R, Pergolizzi S, Tombolini V, Trovo M, Leonardi MC, Ricardi U, Magrini SM, Corvò R, Donato V; on the behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology). Jereczek-Fossa BA, et al. Among authors: catalano g. Radiother Oncol. 2021 Feb;155:120-122. doi: 10.1016/j.radonc.2020.09.049. Epub 2020 Oct 14. Radiother Oncol. 2021. PMID: 33065185 Free PMC article. No abstract available.
Phase II trial of vinorelbine, cisplatin and continuous infusion of 5-fluorouracil followed by hyperfractionated radiotherapy in locally advanced head and neck cancer.
Orecchia R, Jereczek-Fossa BA, Catalano G, Chiesa F, De Pas T, Masci G, Krengli M, Vavassori A, De Paoli F, Robertson C, Marrocco E, De Braud F. Orecchia R, et al. Among authors: catalano g. Oncology. 2002;63(2):115-23. doi: 10.1159/000063803. Oncology. 2002. PMID: 12239445 Clinical Trial.
Optimization of the schedule of gemcitabine-cisplatin combination as induction regimen for patients with biopsy-proven stage IIIa N2 - stage IIIb non-small-cell lung cancer: a prospective phase-II study.
De Pas T, Curigliano G, Veronesi G, Catalano G, Catania C, Jereczek-Fossa B, Orecchia R, Spaggiari L, de Braud F. De Pas T, et al. Among authors: catalano g. Bull Cancer. 2004 Sep 1;91(9):E273-7. Print 2004 Sep. Bull Cancer. 2004. PMID: 15582897 Free article. Clinical Trial.
Linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancer.
Jereczek-Fossa BA, Fariselli L, Beltramo G, Catalano G, Serafini F, Garibaldi C, Cambria R, Brait L, Possanzini M, Bianchi LC, Vavassori A, Zerini D, Orsi F, de Cobelli O, Orecchia R. Jereczek-Fossa BA, et al. Among authors: catalano g. Radiother Oncol. 2009 Oct;93(1):14-7. doi: 10.1016/j.radonc.2009.04.001. Epub 2009 May 4. Radiother Oncol. 2009. PMID: 19409636
Linac-based stereotactic body radiotherapy for oligometastatic patients with single abdominal lymph node recurrent cancer.
Jereczek-Fossa BA, Piperno G, Ronchi S, Catalano G, Fodor C, Cambria R, Fossati Ing P, Gherardi F, Alterio D, Zerini D, Garibaldi C, Baroni G, De Cobelli O, Orecchia R. Jereczek-Fossa BA, et al. Among authors: catalano g. Am J Clin Oncol. 2014 Jun;37(3):227-33. doi: 10.1097/COC.0b013e3182610878. Am J Clin Oncol. 2014. PMID: 22992626
696 results